| Hhs Behavioral Healthcare, Inc | |
|
1126 W Airline Hwy La Place LA 70068-3717 | |
| (985) 651-4612 | |
| (985) 651-4613 |
| Full Name | Hhs Behavioral Healthcare, Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1126 W Airline Hwy, La Place, Louisiana |
| Authorized Official Name and Position | Taquana Mason (CEO) |
| Authorized Official Contact | 5044027122 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Hhs Behavioral Healthcare, Inc Po Box 2708 La Place LA 70069-2708 Ph: (985) 651-4612 | Hhs Behavioral Healthcare, Inc 1126 W Airline Hwy La Place LA 70068-3717 Ph: (985) 651-4612 |
| NPI Number | 1063687093 |
|---|---|
| Provider Enumeration Date | 04/30/2008 |
| Last Update Date | 02/06/2024 |
| Certification Date | 02/06/2024 |
| Medicare PECOS PAC ID | 5496157026 |
|---|---|
| Medicare Enrollment ID | O20210706001287 |
News Archive
A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Life Technologies Corporation today announced it has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research.
Working with yeast and human cells, researchers at Johns Hopkins say they have discovered an unexpected route for cells to eliminate protein clumps that may sometimes be the molecular equivalent of throwing too much or the wrong trash into the garbage disposal.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063687093 | NPI | - | NPPES |
| Provider Name | Antonio D Edwards |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1568515419 PECOS PAC ID: 2264328418 Enrollment ID: I20080721000621 |
News Archive
A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Life Technologies Corporation today announced it has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research.
Working with yeast and human cells, researchers at Johns Hopkins say they have discovered an unexpected route for cells to eliminate protein clumps that may sometimes be the molecular equivalent of throwing too much or the wrong trash into the garbage disposal.
› Verified 9 days ago
News Archive
A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Life Technologies Corporation today announced it has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research.
Working with yeast and human cells, researchers at Johns Hopkins say they have discovered an unexpected route for cells to eliminate protein clumps that may sometimes be the molecular equivalent of throwing too much or the wrong trash into the garbage disposal.
› Verified 9 days ago
Absoulte Health Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 560 Belle Terre Blvd, La Place, LA 70068 Phone: 985-652-0078 | |
Cognitive Development Center Of River Parishes Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 576 Belle Terre Blvd, La Place, LA 70068 Phone: 318-614-7644 | |
River Parishes Assessment Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1809 W Airline Hwy, La Place, LA 70068 Phone: 985-652-8444 Fax: 985-652-2450 | |
Innovative Approaches Counseling Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1317 W Airline Hwy, Suite J, La Place, LA 70068 Phone: 504-259-8614 | |
Aligned Journey Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2321 Williamsburg Dr, La Place, LA 70068 Phone: 504-343-1289 | |
Greater You Counseling Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 429 W Airline Hwy Ste H, La Place, LA 70068 Phone: 985-618-3403 Fax: 985-618-3404 |